Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G T Budd

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findingsR M Bukowski, T Olencki, H Gunn, et al.
The Annals of Thoracic Surgery|September 1, 1995
Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancerT W Rice, D J Adelstein, A Koka, et al.
Leukemia|September 30, 2005
Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706M A Hussein, H Gundacker, D R Head, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 1, 1997
Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of responseR M Bukowski, T Olencki, Q Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinomaR M Bukowski, P Rayman, L Molto, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|December 1, 1991
Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experienceE M Hersh, B S Metch, F M Muggia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup studyC W Taylor, S Green, W S Dalton, et al.
Advances in Experimental Medicine and Biology|March 10, 2000
Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposisG D Stoner, G T Budd, R Ganapathi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancerS E Jones, J Erban, B Overmoyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposisR van Stolk, G Stoner, W L Hayton, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findingsR M Bukowski, T Olencki, H Gunn, et al.
The Annals of Thoracic Surgery|September 1, 1995
Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancerT W Rice, D J Adelstein, A Koka, et al.
Leukemia|September 30, 2005
Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706M A Hussein, H Gundacker, D R Head, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 1, 1997
Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of responseR M Bukowski, T Olencki, Q Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinomaR M Bukowski, P Rayman, L Molto, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|December 1, 1991
Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experienceE M Hersh, B S Metch, F M Muggia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup studyC W Taylor, S Green, W S Dalton, et al.
Advances in Experimental Medicine and Biology|March 10, 2000
Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposisG D Stoner, G T Budd, R Ganapathi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancerS E Jones, J Erban, B Overmoyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposisR van Stolk, G Stoner, W L Hayton, et al.
Pageof 7